Home Page
Events
Proneuron Biotechnologies: Treatment for Spinal Cord Injury and other Neurological Disorders
Home Page
   Company
 
      Technology
 
       Therapies
 
       Clinical Studies
 
      News & Events
 
     Links
 
   Careers
 

Lecture to ASIA (American Spinal Injury Association), Denver, 14-16/05/2004

Activated Autologous Macrophages Therapy for Spinal Cord Injury: characterization of the cellular phenotype

Ina Sarel, Shahar Ish-Shalom, Ronit Bakimer, Orly Aziz, Eilat Bain, Michal Schrift-Tzadok, Marina Bubis, Yona Geffen, Jonathan B. Marder, Ziv Shulman and Eti Yoles
Proneuron Biotechnologies, Ness Ziona, Israel

Objective: Complete spinal cord injury leads to irreversible motor and sensory functional loss. The immune system is the body's machinery for wound healing and repair. However, the central nervous system's wound-healing response is less effective because of its "immune- privileged" character. Spinal cord injured rats, implanted with macrophages that were previously co-incubated with sciatic nerve or skin, show significantly improved functional recovery. Based on the encouraging preclinical animal results, we are conducting a phase II clinical trial of a cell therapy for patients with acute spinal cord injury. Here we report on characterization of the therapeutic macrophages.

Design: Monocytes isolated from peripheral blood of human donors were stimulated by co-incubation with skin tissue, producing a distinct cellular phenotype associated with wound healing.

Methods: The incubated cells were analyzed for morphological characteristics, the expression of membrane markers and cytokine secretion.

Results: Skin co-incubation caused significant increase in granule number and size, and changes in granule contents. Skin-coincubated macrophages expressed higher levels of the costimulatory molecules CD80 and CD86, and of adhesion molecule ICAM1 (CD54), reminiscent of antigen presenting cells. Additionally, co-incubation with skin resulted in increased secretion of the proinflammatory cytokine interleukin 1-beta and of Brain-Derived Neurotrophic Factor.

Conclusions: The above features of skin-coincubated macrophages suggest possible mechanisms by which they may support an immune response that promotes neuronal cell survival and repair.

 

Disclaimer | Site Map | Home Page| Contact Us

Proneuron Biotechnologies is engaged in research
related to spinal cord injuries and paralysis cure.

Top of page Print this page


















Our friends on the web
Judaica Shop
Spinal Cord Injury
Virtual Keyboard
Spinal Cord Injuries
Flowers Israel
Mobile NoteTaker
Marine Construction
Systems On Module
Rugged Computers
Mobile Phone Disabler
Digital Pen